XML 38 R27.htm IDEA: XBRL DOCUMENT v3.25.3

BASIS OF PRESENTATION (Tables)

9 Months Ended

Sep. 30, 2025

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Schedule of Revision of Previously Issued Financial Statements

Accordingly, the Company made corrections, as disclosed in the table below, to the condensed consolidated financial statements for the three months ended September 30, 2024:

(In thousands, except per share data)			As previously reported						Impact of revision						As adjusted
Condensed Consolidated Statement of Operations
Revenue:
Financial Health			$	54,271					$	401					$	54,672
Patient Care			29,559						469						30,028
Total revenue			$	83,830					$	870					$	84,700
Operating income			1,944						870						2,814
Income (loss) before taxes			(2,465)						870						(1,595)
Provision for income taxes			7,344						209						7,553
Net income (loss)			(9,809)						661						(9,148)
Net income (loss) per share - basic			$	(0.66)					$	0.05					(0.61)
Net income (loss) per share - diluted			$	(0.66)					$	0.05					(0.61)
Condensed Consolidated Statement of Comprehensive Income (Loss)
Net income (loss)			$	(9,809)					$	661					$	(9,148)
Comprehensive income (loss)			(9,810)						661						(9,149)
Condensed Consolidated Statement of Equity
Accumulated earnings (deficit) at June 30, 2024			$	567					$	(1,322)					$	(755)
Total stockholders’ equity at June 30, 2024			181,102						(1,322)						179,780
Net income (loss)			(9,809)						661						(9,148)
Accumulated earnings (deficit) at September 30, 2024			(9,242)						(661)						(9,903)
Total stockholders’ equity at September 30, 2024			172,647						(661)						171,986

The Company made corrections, as disclosed in the table below, to the condensed consolidated financial statements for the nine months ended September 30, 2024:

(In thousands, except per share data)			As previously reported						Impact of revision						As adjusted
Condensed Consolidated Statement of Operations
Revenue:
Financial Health			$	161,417					$	1,203					$	162,620
Patient Care			90,389						1,407						91,796
Total revenue			$	251,806					$	2,610					$	254,416
Operating income (loss)			(2,534)						2,610						76
Income (loss) before taxes			(13,743)						2,610						(11,133)
Provision for (benefit from) income taxes			3,631						626						4,257
Net income (loss)			(17,374)						1,984						(15,390)
Net income (loss) per share - basic			$	(1.17)					$	0.13					(1.04)
Net income (loss) per share - diluted			$	(1.17)					$	0.13					(1.04)
Condensed Consolidated Statement of Comprehensive Income (Loss)
Net income (loss)			$	(17,374)					$	1,984					$	(15,390)
Comprehensive income (loss)			(17,267)						1,984						(15,283)
Condensed Consolidated Statement of Equity
Accumulated earnings (deficit) at December 31, 2023			$	8,132					$	(2,645)					$	5,487
Total stockholders’ equity at December 31, 2023			186,618						(2,645)						183,973
Net income (loss)			(17,374)						1,984						(15,390)
Accumulated earnings (deficit) at September 30, 2024			(9,242)						(661)						(9,903)
Total stockholders’ equity at September 30, 2024			172,647						(661)						171,986
Condensed Consolidated Statement of Cash Flows
Net income (loss)			$	(17,374)					$	1,984					$	(15,390)
Accounts receivable			2,946						(2,610)						336
Income taxes, net			(344)						626						282

X

- References

No definition available.

+ Details

Name:	us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of prior period adjustments to previously issued financial statements including (1) the effect of the correction on each financial statement line item and any per-share amounts affected for each prior period presented (2) the cumulative effect of the change on retained earnings or other appropriate components of equity or net assets in the statement of financial position, as of the beginning of the earliest period presented, and (3) the effect of the prior period adjustments (both gross and net of applicable income tax) on the net income of each prior period presented in the entity's annual report for the year in which the adjustments are made.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 7
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-7

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 8
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-8

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 9
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-9

+ Details

Name:	us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration